Racura Oncology Receives Positive SRC Recommendation for CPACS Trial Continuing with RC220#Australia#Sydney#Racura_Oncology#RC220#CPACS_Clinical_Trial
Racura Oncology Receives Positive SRC Recommendation for CPACS Trial Continuing with RC220
Racura Oncology's ongoing CPACS clinical trial for RC220 has received a positive recommendation from its Safety Review Committee, paving the way for further development.
third-news.com
May 15, 2026 at 11:08 AM
Racura Oncology Receives Positive SRC Recommendation for CPACS Trial Continuing with RC220#Australia#Sydney#Racura_Oncology#RC220#CPACS_Clinical_Trial